<DOC>
	<DOCNO>NCT00893815</DOCNO>
	<brief_summary>Despite advent highly active antiretroviral therapy ( HAART ) , prevalence neurocognitive impairment among HIV-infected patient continue important issue . Although severe form AIDS-related dementia diminish , mild form cognitive impairment note among approximately 30 % asymptomatic HIV patient . Studies among HIV-infected U.S. military personnel regard neurocognitive function largely limit early 1990s , advent HAART . In study subtle neurobehavioral change note among asymptomatic HIV-positive military personnel . This study propose determine prevalence neurocognitive deficit among HIV-positive military beneficiary era HAART participant U.S. Military HIV Natural History Study . The prevalence ascertain study compare HIV-negative military beneficiary demographically similar HIV positive group . The sample size study complete test 200 HIV positive 50 HIV-negative participant ; due possibility attrition study completion , investigator enroll 300 participant ( 240 HIV-positive 60 HIV-negative ) achieve sample size . The investigator ' rate among HIV-positive patient find study also contextualized set prevalence prior neurocognitive deficit see HIV positive U.S. military population study 1990s , contemporary rate among civilian HIV-infected person , normative value general HIV-negative population . Compared data field neuropsychology , study novel HIV population study compose largely HIV patient diagnose early HIV infection ; open , free access antiretrovirals begin therapy early cohort ; consist highly-functioning , educate individual .</brief_summary>
	<brief_title>Prevalence Predictors Neurocognitive Impairment Among HIV-infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIV Positive Group : HIVinfected patient 1850 year age Current participant U.S. Military HIV Natural History Study ( RV168 ) Current suicidal ideation Inability unwillingness complete full abbreviate neuropsychological battery questionnaires An acute medical condition may impact participant 's ability complete test may significant impact test result deem site research physician ( e.g. , pneumonia , influenza ) ; subject may participate later date physician deem acute medical illness resolve . HIV Negative Group : Between 18 50 year age . A military beneficiary HIV negative ELISA drawn within one year study enrollment ( willingness HIV test perform negative result ) Inability unwillingness complete full abbreviate neuropsychological battery questionnaire Presence current suicidal thought An acute medical condition may impact participant 's ability complete test may significant impact test result deem site research physician ( e.g. , pneumonia , influenza ) ; subject may participate later date physician deem acute medical illness resolve .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Neurocognitive function</keyword>
</DOC>